151 related articles for article (PubMed ID: 34889867)
1. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas.
Uhlig R; Contreras H; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Wilczak W; Izbicki J; Perez D; Schrader J; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R; Minner S; Jacobsen F; Clauditz TS
Am J Surg Pathol; 2022 Jan; 46(1):97-104. PubMed ID: 34889867
[TBL] [Abstract][Full Text] [Related]
2. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.
Ishimoto-Namiki U; Ino Y; Esaki M; Shimada K; Saruta M; Hiraoka N
Am J Surg Pathol; 2023 May; 47(5):525-534. PubMed ID: 36815573
[TBL] [Abstract][Full Text] [Related]
4. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic acinar cell carcinoma.
Ordóñez NG
Adv Anat Pathol; 2001 May; 8(3):144-59. PubMed ID: 11345238
[TBL] [Abstract][Full Text] [Related]
6. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
8. CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas.
Uhlig R; Bröker N; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Lennartz M; Reiswich V; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Burandt E; Krech R; Dum D; Marx A; Simon R; Krech T; Clauditz TS; Jacobsen F
PLoS One; 2023; 18(6):e0287528. PubMed ID: 37379306
[TBL] [Abstract][Full Text] [Related]
9. Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma.
Ohike N; Kosmahl M; Klöppel G
Virchows Arch; 2004 Sep; 445(3):231-5. PubMed ID: 15517367
[TBL] [Abstract][Full Text] [Related]
10. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.
Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of pancreatic acinar differentiation in gastric adenocarcinoma: report of a case and immunohistochemical study of 111 additional cases.
Lee H; Tang LH; Veras EF; Klimstra DS
Am J Surg Pathol; 2012 Mar; 36(3):402-8. PubMed ID: 22082608
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
Sanati S; Watson MA; Salavaggione AL; Humphrey PA
Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
14. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.
Dwertmann Rico S; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Isbert C; Fraune C; Möller K; Menz A; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Burandt E; Marx A; Krech T
Int J Immunopathol Pharmacol; 2022; 36():3946320221106504. PubMed ID: 35764407
[No Abstract] [Full Text] [Related]
15. Mutations in the pancreatic secretory enzymes
Tamura K; Yu J; Hata T; Suenaga M; Shindo K; Abe T; MacGregor-Das A; Borges M; Wolfgang CL; Weiss MJ; He J; Canto MI; Petersen GM; Gallinger S; Syngal S; Brand RE; Rustgi A; Olson SH; Stoffel E; Cote ML; Zogopoulos G; Potash JB; Goes FS; McCombie RW; Zandi PP; Pirooznia M; Kramer M; Parla J; Eshleman JR; Roberts NJ; Hruban RH; Klein AP; Goggins M
Proc Natl Acad Sci U S A; 2018 May; 115(18):4767-4772. PubMed ID: 29669919
[TBL] [Abstract][Full Text] [Related]
16. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
[TBL] [Abstract][Full Text] [Related]
18. Total pancreatectomy for metachronous mixed acinar-ductal carcinoma in a remnant pancreas.
Shonaka T; Inagaki M; Akabane H; Yanagida N; Shomura H; Yanagawa N; Oikawa K; Nakano S
World J Gastroenterol; 2014 Sep; 20(33):11904-9. PubMed ID: 25206298
[TBL] [Abstract][Full Text] [Related]
19. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
